کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2077448 | 1079711 | 2014 | 14 صفحه PDF | دانلود رایگان |
• Hematopoietic stem and multipotent progenitor cells (MPPs) express ERα
• ERα activation induces apoptosis of MPPs and proliferation of LT-HSCs
• Tamoxifen blocks JAK2V617F-induced myeloproliferative neoplasia in mice
• Tamoxifen enhances chemotherapy response of MLL-AF9-induced leukemias
SummaryEstrogens are potent regulators of mature hematopoietic cells; however, their effects on primitive and malignant hematopoietic cells remain unclear. Using genetic and pharmacological approaches, we observed differential expression and function of estrogen receptors (ERs) in hematopoietic stem cell (HSC) and progenitor subsets. ERα activation with the selective ER modulator (SERM) tamoxifen induced apoptosis in short-term HSCs and multipotent progenitors. In contrast, tamoxifen induced proliferation of quiescent long-term HSCs, altered the expression of self-renewal genes, and compromised hematopoietic reconstitution after myelotoxic stress, which was reversible. In mice, tamoxifen treatment blocked development of JAK2V617F-induced myeloproliferative neoplasm in vivo, induced apoptosis of human JAK2V617F+ HSPCs in a xenograft model, and sensitized MLL-AF9+ leukemias to chemotherapy. Apoptosis was selectively observed in mutant cells, and tamoxifen treatment only had a minor impact on steady-state hematopoiesis in disease-free animals. Together, these results uncover specific regulation of hematopoietic progenitors by estrogens and potential antileukemic properties of SERMs.
Graphical AbstractFigure optionsDownload high-quality image (423 K)Download as PowerPoint slide
Journal: - Volume 15, Issue 6, 4 December 2014, Pages 791–804